MERRIMACK PHARMACEUTICALS INC Selling, General and Administrative Expense
MERRIMACK PHARMACEUTICALS INC reported Selling, General and Administrative Expense of $5.63 million for the 3-month period ending 2017-03-31, per its 10-Q filed 2017-05-10.
Discontinued › Expense Statement › Operating Expenses
us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2017-05-10
- MERRIMACK PHARMACEUTICALS INC selling, general and administrative expense for the quarter ending 2017-03-31 was $5.63M, a 12.68% decline year-over-year.
- MERRIMACK PHARMACEUTICALS INC selling, general and administrative expense for the quarter ending 2016-12-31 was $24.21M, a 25.19% increase year-over-year.
- MERRIMACK PHARMACEUTICALS INC selling, general and administrative expense for the quarter ending 2016-09-30 was $18.05M, a 6.44% increase year-over-year.
- MERRIMACK PHARMACEUTICALS INC selling, general and administrative expense for the quarter ending 2016-06-30 was $20.68M, a 67.93% increase year-over-year.
- MERRIMACK PHARMACEUTICALS INC selling, general and administrative expense for fiscal 2016 was $80.73M, a 39.68% increase from fiscal 2015.
- MERRIMACK PHARMACEUTICALS INC selling, general and administrative expense for fiscal 2015 was $57.80M, a 89.39% increase from fiscal 2014.
- MERRIMACK PHARMACEUTICALS INC selling, general and administrative expense for fiscal 2014 was $30.52M, a 44.04% increase from fiscal 2013.
- MERRIMACK PHARMACEUTICALS INC selling, general and administrative expense for fiscal 2013 was $21.19M.
| Period end | Selling, General and Administrative Expense 3 month | Selling, General and Administrative Expense 3 month as first filed | Selling, General and Administrative Expense 6 month | Selling, General and Administrative Expense 9 month | Selling, General and Administrative Expense 12 month |
|---|---|---|---|---|---|
| 2017-03-31 | $5.63M 10-Q · filed 2017-05-10 | $29.84M derived: sum of 2 quarters · filed 2017-05-10 | $47.89M derived: sum of 3 quarters · filed 2017-05-10 | $68.57M derived: sum of 4 quarters · filed 2017-05-10 | |
| 2016-12-31 | $24.21M 10-K · filed 2017-03-01 | $42.25M derived: sum of 2 quarters · filed 2017-03-01 | $62.93M derived: sum of 3 quarters · filed 2017-03-01 | $80.73M 10-K · filed 2017-03-01 | |
| 2016-09-30 | $18.05M 10-K · filed 2017-03-01 | $38.73M derived: sum of 2 quarters · filed 2017-03-01 | $56.52M 10-Q · filed 2016-11-09 | $64.52M derived: sum of 4 quarters · filed 2017-05-10 | |
| 2016-06-30 | $20.68M 10-K · filed 2017-03-01 | $38.48M 10-Q · filed 2016-08-04 | $46.47M derived: sum of 3 quarters · filed 2017-05-10 | $63.42M derived: sum of 4 quarters · filed 2017-05-10 | |
| 2016-03-31 | $6.45M 10-Q · filed 2017-05-10 | $17.80M 10-Q · filed 2016-05-02 | $25.79M derived: sum of 2 quarters · filed 2017-05-10 | $42.74M derived: sum of 3 quarters · filed 2017-05-10 | $55.06M derived: sum of 4 quarters · filed 2017-05-10 |
| 2015-12-31 | $19.34M 10-K · filed 2017-03-01 | $36.29M derived: sum of 2 quarters · filed 2017-03-01 | $48.61M derived: sum of 3 quarters · filed 2017-03-01 | $57.80M 10-K · filed 2017-03-01 | |
| 2015-09-30 | $16.96M 10-K · filed 2017-03-01 | $29.27M derived: sum of 2 quarters · filed 2017-03-01 | $38.46M 10-Q · filed 2016-11-09 | $46.74M derived: sum of 4 quarters · filed 2017-03-01 | |
| 2015-06-30 | $12.31M 10-K · filed 2017-03-01 | $21.50M 10-Q · filed 2016-08-04 | $29.78M derived: sum of 3 quarters · filed 2017-03-01 | $37.88M derived: sum of 4 quarters · filed 2017-03-01 | |
| 2015-03-31 | $9.19M 10-K · filed 2017-03-01 | $17.47M derived: sum of 2 quarters · filed 2017-03-01 | $25.56M derived: sum of 3 quarters · filed 2017-03-01 | $33.48M derived: sum of 4 quarters · filed 2017-03-01 | |
| 2014-12-31 | $8.28M 10-K · filed 2016-02-26 | $16.37M derived: sum of 2 quarters · filed 2016-02-26 | $24.29M derived: sum of 3 quarters · filed 2016-02-26 | $30.52M 10-K · filed 2017-03-01 | |
| 2014-09-30 | $8.10M 10-K · filed 2016-02-26 | $16.02M derived: sum of 2 quarters · filed 2016-02-26 | $22.24M derived: sum of 3 quarters · filed 2016-02-26 | ||
| 2014-06-30 | $7.92M 10-K · filed 2016-02-26 | $14.14M derived: sum of 2 quarters · filed 2016-02-26 | |||
| 2014-03-31 | $6.22M 10-K · filed 2016-02-26 | ||||
| 2013-12-31 | $21.19M 10-K · filed 2016-02-26 |